9/27/2022 7:02:33 AM
Merck Animal Health Completes Minority Investment In LeeO Precision Farming
9/22/2022 7:34:15 AM
Merck Animal Health To Acquire Vence; Terms Undisclosed
9/22/2022 7:27:20 AM
U.S. District Court Rules In Favor Of Merck In Sitagliptin Phosphate Patent Lawsuit
9/13/2022 7:27:10 AM
Medicenna Announces Clinical Collaboration With Merck To Evaluate MDNA11 With KEYTRUDA In ABILITY Trial
9/13/2022 7:13:12 AM
Merck: Health Canada Approves KEYTRUDA For Stage IIB Or IIC Melanoma Following Complete Resection
9/12/2022 9:02:23 AM
Astellas Reports Results Of Trial Of PADCEV -KEYTRUDA &PADCEV As Monotherapy In First-Line Advanced Urothelial Cancer
9/9/2022 8:04:52 AM
AstraZeneca : LYNPARZA Combination Shows Meaningful Survival Benefit In Ovarian Cancer Across Phase III Trials
8/23/2022 7:21:17 AM
Merck Gets Fast Track Designation From FDA For MK-2060, An Investigational Anticoagulant Therapy